Abstract
Modification of nepafenac intermediate synthesis (5A) via Gassman specific ortho-substitution is reported. According to the process, 2-aminobenzophenone (1A) and 2-(methylthio)acetamide (2) were reacted in the convenient temperature conditions, in the presence of N-chlorophthalimide (3) or 1,3-dichloro-5,5-dimethylhydantoin (4), to activate the formation of azasulfonium salt and rearrangement thereof to pure 2-amino-3-benzoyl-α-(methylthio)phenylacetamide (5A). The procedure appears to be suitable for a reaction carried out in a large scale.
Keywords: Gasmann reaction, Nepafenac, N-chlorophthalimide, Sommelet-Hauser-type rearrangement, N-chloroaniline, 2-(methylthio)acetamide, chlorosulfonium, salt, sulfoxide, oxalyl
Letters in Organic Chemistry
Title:Development and a Practical Synthesis of Nepafenac Intermediate via Modified Gassman Reaction
Volume: 9 Issue: 7
Author(s): Marcin Cybulski, Adam Formela, Mariola Mucha, Karolina Klos, Jacek Roszczynski and Jerzy Winiarski
Affiliation:
Keywords: Gasmann reaction, Nepafenac, N-chlorophthalimide, Sommelet-Hauser-type rearrangement, N-chloroaniline, 2-(methylthio)acetamide, chlorosulfonium, salt, sulfoxide, oxalyl
Abstract: Modification of nepafenac intermediate synthesis (5A) via Gassman specific ortho-substitution is reported. According to the process, 2-aminobenzophenone (1A) and 2-(methylthio)acetamide (2) were reacted in the convenient temperature conditions, in the presence of N-chlorophthalimide (3) or 1,3-dichloro-5,5-dimethylhydantoin (4), to activate the formation of azasulfonium salt and rearrangement thereof to pure 2-amino-3-benzoyl-α-(methylthio)phenylacetamide (5A). The procedure appears to be suitable for a reaction carried out in a large scale.
Export Options
About this article
Cite this article as:
Cybulski Marcin, Formela Adam, Mucha Mariola, Klos Karolina, Roszczynski Jacek and Winiarski Jerzy, Development and a Practical Synthesis of Nepafenac Intermediate via Modified Gassman Reaction, Letters in Organic Chemistry 2012; 9 (7) . https://dx.doi.org/10.2174/157017812802139582
DOI https://dx.doi.org/10.2174/157017812802139582 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neonatal Necrotizing Enterocolitis – Inflammation and Intestinal Immaturity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patent Selections
Recent Patents on Drug Delivery & Formulation Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile
Current Pharmaceutical Design Pathophysiological Factors which Determine the Exercise Intolerance in Patients with Juvenile Dermatomyositis
Current Rheumatology Reviews Curcumin Combats against Organophosphate Pesticides Toxicity: A Review of the Current Evidence and Molecular Pathways
Current Medicinal Chemistry Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Biological Properties of Baicalein in Cardiovascular System
Current Drug Targets - Cardiovascular & Hematological Disorders Recent Advances in Gastric Floating Drug Delivery Technology: A Review
Current Drug Delivery The Structure and Biological Aspects of Peptide Antibiotic Microcin J25
Current Medicinal Chemistry Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway
Current Medicinal Chemistry Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules
Current Medicinal Chemistry Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging Two-Domain Vascular Disruptive Agents in Cancer Therapy
Current Cancer Drug Targets A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Pharmaceutical Design Biological Therapies: Effects of Proinflammatory Pathways and their Inhibition on the Myocardium of Rheumatoid Athritis Patients
Current Medicinal Chemistry The Blood-Brain Barrier in NeuroAIDS
Current HIV Research Recent Patents Therapeutic Agents for Cancer
Recent Patents on Anti-Cancer Drug Discovery Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery
Current Drug Targets Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms
Endocrine, Metabolic & Immune Disorders - Drug Targets